The PARIS score allows combined stratification of ischemic and hemorrhagic risk in patients with ischemic heart disease treated with coronary stenting and dual antiplatelet therapy (DAPT). Its usefulness in patients with acute coronary syndrome (ACS) treated with ticagrelor or prasugrel is unknown. We investigated this issue in an international registry.
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome / Raposeiras-Roubín, Sergio; Caneiro Queija, Berenice; D'Ascenzo, Fabrizio; Kinnaird, Tim; Ariza-Solé, Albert; Manzano-Fernández, Sergio; Templin, Christian; Velicki, Lazar; Xanthopoulou, Ioanna; Cerrato, Enrico; Quadri, Giorgio; Rognoni, Andrea; Boccuzzi, Giacome; Montabone, Andrea; Taha, Salma; Durante, Alessandro; Gili, Sebastiano; Magnani, Giulia; Autelli, Michele; Grosso, Alberto; Flores Blanco, Pedro; Garay, Alberto; Varbella, Ferdinando; Tomassini, Francesco; Cobas Paz, Rafael; Cespón Fernández, María; Muñoz Pousa, Isabel; Gallo, Diego; Morbiducci, Umberto; Domínguez-Rodríguez, Alberto; Baz-Alonso, José Antonio; Calvo-Iglesias, Francisco; Valdés, Mariano; Cequier, Ángel; Gaita, Fiorenzo; Alexopoulos, Dimitrios; Íñiguez-Romo, Andrés; Abu-Assi, Emad. - In: REVISTA ESPAÑOLA DE CARDIOLOGÍA. - ISSN 1885-5857. - ELETTRONICO. - 72:3(2019), pp. 215-223.
Titolo: | Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome |
Autori: | |
Data di pubblicazione: | 2019 |
Rivista: | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.rec.2018.06.004 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
2019Raposeiras_PARISscore_RevEspCardiol.pdf | Articolo principale | 2a Post-print versione editoriale / Version of Record | Non Pubblico - Accesso privato/ristretto | Administrator Richiedi una copia |
http://hdl.handle.net/11583/2732301